[1]
Karataş, Ömer F. and Ittmann, M. 2018. MiR-33a and statins collaboratively reduce the proliferative capacity of prostate cancer cells. The European Research Journal. 4, 4 (Oct. 2018), 266–274. DOI:https://doi.org/10.18621/eurj.380619.